IL144810A0 - Dopamine d1 receptor agonist compounds - Google Patents
Dopamine d1 receptor agonist compoundsInfo
- Publication number
- IL144810A0 IL144810A0 IL14481000A IL14481000A IL144810A0 IL 144810 A0 IL144810 A0 IL 144810A0 IL 14481000 A IL14481000 A IL 14481000A IL 14481000 A IL14481000 A IL 14481000A IL 144810 A0 IL144810 A0 IL 144810A0
- Authority
- IL
- Israel
- Prior art keywords
- dopamine
- receptor agonist
- agonist compounds
- compounds
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9903671.7A GB9903671D0 (en) | 1999-02-17 | 1999-02-17 | Dopamine D-1 receptor agonist compounds |
| PCT/GB2000/000570 WO2000049000A1 (en) | 1999-02-17 | 2000-02-17 | Dopamine d1 receptor agonist compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL144810A0 true IL144810A0 (en) | 2002-06-30 |
Family
ID=10847990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14481000A IL144810A0 (en) | 1999-02-17 | 2000-02-17 | Dopamine d1 receptor agonist compounds |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1157009A1 (de) |
| JP (1) | JP2002537288A (de) |
| KR (1) | KR20010108228A (de) |
| CN (1) | CN1142916C (de) |
| AU (1) | AU767332B2 (de) |
| BR (1) | BR0008329A (de) |
| CA (1) | CA2363695A1 (de) |
| CZ (1) | CZ20012973A3 (de) |
| EA (1) | EA004745B1 (de) |
| GB (1) | GB9903671D0 (de) |
| HU (1) | HUP0200057A3 (de) |
| IL (1) | IL144810A0 (de) |
| MX (1) | MXPA01008294A (de) |
| NO (1) | NO20013978L (de) |
| PL (1) | PL349838A1 (de) |
| WO (1) | WO2000049000A1 (de) |
| ZA (1) | ZA200106478B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0130576D0 (en) * | 2001-12-20 | 2002-02-06 | Cenes Ltd | Dopamine D1 receptor agonist pro-drug compounds & derivatives |
| KR20080044840A (ko) | 2005-07-15 | 2008-05-21 | 에이엠알 테크놀로지, 인크. | 아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기위한 용도 |
| AU2006278514A1 (en) * | 2005-08-03 | 2007-02-15 | Mia Levite | Killing human lymphoma and leukemia cancer cells and TCR-activated normal human cells by dopamine D1R agonists |
| CN101684096A (zh) * | 2008-09-23 | 2010-03-31 | 中国科学院上海药物研究所 | 一类新型苯并氮杂卓类化合物及其制备方法和用途 |
| CN102276531A (zh) * | 2011-05-30 | 2011-12-14 | 扬子江药业集团广州海瑞药业有限公司 | 一种甲磺酸非诺多泮的制备方法 |
| CA2916653C (en) | 2013-06-27 | 2017-07-18 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine d1 ligands |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1561305A (en) * | 1975-07-02 | 1980-02-20 | Smithkline Corp | Benzazepine derivatives and pharmeceutical compositions containing them |
| US4111957A (en) * | 1977-02-02 | 1978-09-05 | Smithkline Corporation | Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds |
| US4265889A (en) * | 1978-05-05 | 1981-05-05 | Smithkline Corporation | 6-Lower alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
| US4707483A (en) * | 1985-12-20 | 1987-11-17 | Smithkline Beckman Corporation | 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders |
| US4861771A (en) * | 1989-01-27 | 1989-08-29 | Smithkline Beckman Corporation | Carbamates of 6-chloro-7,8-dihydroxy-1-(4'-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine as prodrugs |
-
1999
- 1999-02-17 GB GBGB9903671.7A patent/GB9903671D0/en not_active Ceased
-
2000
- 2000-02-17 IL IL14481000A patent/IL144810A0/xx unknown
- 2000-02-17 KR KR1020017010418A patent/KR20010108228A/ko not_active Application Discontinuation
- 2000-02-17 MX MXPA01008294A patent/MXPA01008294A/es unknown
- 2000-02-17 CZ CZ20012973A patent/CZ20012973A3/cs unknown
- 2000-02-17 BR BR0008329-1A patent/BR0008329A/pt not_active IP Right Cessation
- 2000-02-17 CN CNB00803947XA patent/CN1142916C/zh not_active Expired - Fee Related
- 2000-02-17 HU HU0200057A patent/HUP0200057A3/hu unknown
- 2000-02-17 JP JP2000599740A patent/JP2002537288A/ja active Pending
- 2000-02-17 EP EP00903881A patent/EP1157009A1/de not_active Withdrawn
- 2000-02-17 CA CA002363695A patent/CA2363695A1/en not_active Abandoned
- 2000-02-17 EA EA200100783A patent/EA004745B1/ru not_active IP Right Cessation
- 2000-02-17 PL PL00349838A patent/PL349838A1/xx not_active Application Discontinuation
- 2000-02-17 AU AU25632/00A patent/AU767332B2/en not_active Ceased
- 2000-02-17 WO PCT/GB2000/000570 patent/WO2000049000A1/en not_active Application Discontinuation
-
2001
- 2001-08-07 ZA ZA200106478A patent/ZA200106478B/en unknown
- 2001-08-15 NO NO20013978A patent/NO20013978L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2563200A (en) | 2000-09-04 |
| WO2000049000A1 (en) | 2000-08-24 |
| ZA200106478B (en) | 2002-02-07 |
| HUP0200057A2 (en) | 2002-08-28 |
| NO20013978D0 (no) | 2001-08-15 |
| CN1341102A (zh) | 2002-03-20 |
| NO20013978L (no) | 2001-08-15 |
| BR0008329A (pt) | 2002-01-29 |
| MXPA01008294A (es) | 2002-07-02 |
| AU767332B2 (en) | 2003-11-06 |
| EP1157009A1 (de) | 2001-11-28 |
| KR20010108228A (ko) | 2001-12-07 |
| CN1142916C (zh) | 2004-03-24 |
| CZ20012973A3 (cs) | 2002-01-16 |
| GB9903671D0 (en) | 1999-04-14 |
| EA004745B1 (ru) | 2004-08-26 |
| HUP0200057A3 (en) | 2004-03-29 |
| PL349838A1 (en) | 2002-09-23 |
| CA2363695A1 (en) | 2000-08-24 |
| EA200100783A1 (ru) | 2002-02-28 |
| JP2002537288A (ja) | 2002-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE449768T1 (de) | Triazolverbindungen mit dopamin-d3- rezeptoraffinität | |
| HK1091403A1 (en) | 5-ht 1a receptor subtype agonist | |
| EP1187614A4 (de) | Substituierte piperidine als melanocortin-4 rezeptoragonisten | |
| AU6497701A (en) | Melanocortin receptor agonists | |
| AU2001280568A1 (en) | Heterocyclic beta-3 adrenergic receptor agonists | |
| PL356990A1 (en) | Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists | |
| HUP0202142A2 (en) | Macrophage scavenger receptor antagonists | |
| AU4098501A (en) | Estrogen agonist/antagonist metabolites | |
| AU2001273508A1 (en) | Heterocyclic beta-3 adrenergic receptor agonists | |
| IL146151A0 (en) | Human-g-protein receptor | |
| HUP0101746A3 (en) | Phenylsulfonamide-phenylethylamines usefull as dopamine receptors | |
| IL144810A0 (en) | Dopamine d1 receptor agonist compounds | |
| AU1100300A (en) | Piperidyloxadiazoles as dopamine receptor antagonists | |
| EP1520856A4 (de) | Androgenrezeptorantagonist | |
| AU6230698A (en) | Dopamine d4 receptor antagonist | |
| AU4511901A (en) | Nonpeptide kappa opioid receptor antagonists | |
| GB0130576D0 (en) | Dopamine D1 receptor agonist pro-drug compounds & derivatives | |
| AU4337599A (en) | Substituted 1-aryl-3-benzylaminopyrrolidine: dopamine receptor subtype specific ligands | |
| GB0020710D0 (en) | Dopamine D1 receptor agonist pro-drug compounds & derivatives | |
| SI1077935T1 (en) | Phenylsulfonamide-phenylethylamines useful as dopamine receptors | |
| AU2825100A (en) | Heterocyclic compounds having affinities for serotonin receptors | |
| AU3128700A (en) | Combinations of dopamine receptor antagonists with dopamine agonists | |
| HK1048803A1 (en) | β 2-ADRENERGIC RECEPTOR AGONISTS | |
| PL356171A1 (en) | Beta2-adrenergic receptor agonists | |
| GB0107914D0 (en) | 7tm receptor hlwar77 |